Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
FDA hits Hong Kong OTC drugmaker with warning letter
The FDA issued a warning letter to Hong Kong-based over-the-counter drugmaker Luen Wah Medicine, citing the company for not testing the identity and strength of each active ingredient in its products.
Squeezed Mylan axing 500 jobs in West Virginia to 'right-size' massive plant
To "right-size" what Mylan says is one of the world's largest pharmaceutical plants, the generic drugmaker is laying off about 500 employees in Morgantown, West Virginia.
UK bans Sanofi epilepsy drug without pregnancy prevention plan
LONDON (Reuters) - A Sanofi drug for epilepsy and bipolar disorder linked to thousands of birth defects has been banned in Britain for use in women or girls of child-bearing age, unless they a...
Jilted Akorn sues Fresenius over deal termination
FRANKFURT (Reuters) - U.
Two new lung cancer medicines offer hope
Late-stage lung cancer patients who have built up a tolerance to some drugs may have new hope thanks to two domestically developed medicines, doctors from Shanghai Chest Hospital said on Thursday.
Prostate cancer breakthrough as scientists invent new ultra-accurate non-invasive test for the killer disease
UK scientists have made a breakthrough in prostate cancer research with a new test that could make spotting the killer disease much easier.
FDA declines to approve Pfizer biosimilar of Roche's cancer drug
(Reuters) - Pfizer Inc said on Monday U.
Relapsing MS Patients Who Switched to Aubagio® (teriflunomide) Reported Increased Treatment Satisfaction in Two Clinical Studies
CAMBRIDGE, Mass.
Good news, Glaxo: Novartis' Advair copy definitely won't see the market this year
Novartis’ prospects for launching a copy of GlaxoSmithKline’s Advair this year just went from highly unlikely to not happening.
Shire rejects £43bn offer from Japan's Takeda
Japan's Takeda Pharmaceutical is in talks with Shire after making a £43bn bid for the London-listed rare diseases drug maker.
Biogen boosts investment in neurology with $1 billion Ionis deal
(Reuters) - Biogen Inc struck a $1 billion neurology drug development deal with Ionis Pharmaceuticals on Friday, expanding a partnership that developed the company’s potential blockbuster dr...
GW Pharma gets FDA panel nod, first cannabis-based drug nearing approval
(Reuters) - An advisory panel to the U.
445
446
447
448
449
450
451
452
453
